GILD Jan 2025 40.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:17PM EDT. Market open.
| Previous Close | 36.30 |
| Open | 35.51 |
| Bid | 26.90 |
| Ask | 30.10 |
| Strike | 40.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 35.47 - 36.30 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 43 |
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
ZacksIncyte (INCY) Earnings Expected to Grow: Should You Buy?
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksGilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
© 2024 Yahoo. All rights reserved.